This is a Orlando news story, published by NBC News, that relates primarily to Wegovy news.
For more Orlando news, you can click here:
more Orlando newsFor more Wegovy news, you can click here:
more Wegovy newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from NBC News, you can click here:
more news from NBC NewsOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
upcoming weight loss drugs. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest weight loss drugs news, GLP drugs news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
obesity drugsNBC News
•
86% Informative
At the 2024 American Diabetes Association conference in Orlando , Florida , researchers are expected to present data on 27 GLP-1 drugs in development.
Some of the experimental drugs may go beyond diabetes and weight loss, improving liver and heart function.
Approval by the Food and Drug Administration is likely years away for most.
A month ’s supply of Wegovy or Zepbound can cost more than $1,000 .
Competition could drive down the high cost of the drugs over time, experts say.
Patients respond differently to treatments, expert says.
Some patients have found the existing GLP-1 options ineffective.
VR Score
85
Informative language
83
Neutral language
70
Article tone
formal
Language
English
Language complexity
49
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
8
Source diversity
7
Affiliate links
no affiliate links